Cormark Raises Vitalhub (TSE:VHI) Price Target to C$10.50

Vitalhub (TSE:VHI) had its price target upped by Cormark from C$9.50 to C$10.50 in a research report report published on Wednesday morning, BayStreet.CA reports. They currently have a buy rating on the stock. Cormark also issued estimates for Vitalhub’s FY2025 earnings at $0.22 EPS.

Vitalhub Stock Performance

VHI stock opened at C$8.97 on Wednesday. The stock has a market cap of C$456.12 million, a P/E ratio of 81.55, a P/E/G ratio of 1.18 and a beta of 1.26. The firm has a 50 day simple moving average of C$8.34 and a 200 day simple moving average of C$7.33. Vitalhub has a 52 week low of C$2.75 and a 52 week high of C$9.09.

Vitalhub (TSE:VHI) last posted its quarterly earnings results on Thursday, August 8th. The company reported C($0.01) EPS for the quarter, missing the consensus estimate of C$0.06 by C($0.07). Vitalhub had a net margin of 8.14% and a return on equity of 4.73%. The company had revenue of C$16.24 million for the quarter, compared to analysts’ expectations of C$15.39 million. Sell-side analysts predict that Vitalhub will post 0.2301144 EPS for the current year.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.